Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Mimouni

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Archives of Dermatological Research|April 18, 2013
A prospective study on clinical response and cell-mediated immunity of pemphigus patients treated with rituximabY A Leshem, M David, E Hodak, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 24, 2014
Pemphigus. S2 Guideline for diagnosis and treatment--guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)M Hertl, H Jedlickova, S Karpati, et al.
The British Journal of Dermatology|April 2, 2015
Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and VenereologyC Feliciani, P Joly, M F Jonkman, et al.
Experimental Dermatology|September 21, 2006
Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just "witnesses of disease"?M Amagai, A R Ahmed, Y Kitajima, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 25, 2020
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)P Joly, B Horvath, Α Patsatsi, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Archives of Dermatological Research|April 18, 2013
A prospective study on clinical response and cell-mediated immunity of pemphigus patients treated with rituximabY A Leshem, M David, E Hodak, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 24, 2014
Pemphigus. S2 Guideline for diagnosis and treatment--guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)M Hertl, H Jedlickova, S Karpati, et al.
The British Journal of Dermatology|April 2, 2015
Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and VenereologyC Feliciani, P Joly, M F Jonkman, et al.
Experimental Dermatology|September 21, 2006
Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just "witnesses of disease"?M Amagai, A R Ahmed, Y Kitajima, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 25, 2020
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)P Joly, B Horvath, Α Patsatsi, et al.
Pageof 7